Monday, April 1, 2013

Wall Street’s New Drug of Choice



From New York Magazine: "….Modafinil, which is marketed as Provigil in the United States, was first approved by the FDA in 1998 for the treatment of narcolepsy, but since then it’s become better known as a nootropic, a “smart drug,” especially among entrepreneurs. More recently, it has attracted traders like Borden who don’t just need a pick-me-up to get through a deadline; they need to be on, without a break, for months, even years at a time...

Tasks that were usually soul-crushing now had his undivided attention. He spent hours fine-tuning ad campaigns for his new business, and his output wasn’t just faster and longer—it was better. “I didn’t take as many breaks; I didn’t get as frustrated; the stuff came out with fewer errors,” he says. “I never felt, Oh, let’s just get it done. I polished things.” As long as he kept taking the pill, his focus never wavered. “Time took on an entirely different sort of quality.” He was even happier. “There were some very potent anti-anxiety effects. Which was strange. I didn’t think I was an anxious person, but I guess I was.”

….And that’s modafinil’s reputation. It is rumored to be the model for the fictional pills in the movie Limitless that allowed Bradley Cooper’s character to use 100 percent of his brain…..

More?  Check out http://nymag.com/news/intelligencer/modafinil-2013-4/

No comments:

Post a Comment